Merck has strong fourth quarter as COVID-19 treatment debuts
The blockbuster cancer treatment Keytruda pushed Merck past fourth-quarter expectations,...
Source: lmtonline.com
š° Actset News
Page 30 - Actset News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Actset. Real-time updates on events, politics, business and more.
Biogen's 2022 outlook leaves investors wanting, shares slip
Biogen expects āminimalā revenue this year from its Alzheimerās treatment initially...
Source: wiltonbulletin.com
Biogen's 2022 outlook leaves investors wanting, shares slip
Biogen expects āminimalā sales this year from its Alzheimerās treatment initially...
Source: ctinsider.com
Biogen's 2022 outlook leaves investors wanting, shares slip
Biogen expects āminimalā sales this year from its Alzheimerās treatment initially...
Source: darientimes.com
Biogen's 2022 outlook leaves investors wanting, shares slip
Biogen expects āminimalā sales this year from its Alzheimerās treatment initially...
Source: ctpost.com
Biogen's 2022 outlook leaves investors wanting, shares slip
Biogen expects āminimalā sales this year from its Alzheimerās treatment initially...
Source: theridgefieldpress.com
Biogen's 2022 outlook leaves investors wanting, shares slip
Biogen expects āminimalā sales this year from its Alzheimerās treatment initially...
Source: ncadvertiser.com
Biogen's 2022 outlook leaves investors wanting, shares slip
Biogen expects āminimalā sales this year from its Alzheimerās treatment initially...
Source: trumbulltimes.com
Biogen's 2022 outlook leaves investors wanting, shares slip
Biogen expects āminimalā sales this year from its Alzheimerās treatment initially...
Source: expressnews.com
Merck has strong fourth quarter as COVID-19 treatment debuts
The blockbuster cancer treatment Keytruda pushed Merck past fourth-quarter expectations,...
Source: sheltonherald.com